Protective effect of Boerhaavia diffusa L.against mitochondrial dysfunction in angiotensin II induced hypertrophy in H9c2 cardiomyoblast cells

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Prathapan, Ayyappan ^a   Vineetha, Vadavanath Prabhakaran ^a   Raghu, Kozhiparambil Gopalan ^a  

^a REGIONAL RESEARCH LABORATORY CSIR   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACONITATE HYDRATASE; ALCOHOL; ANGIOTENSIN II; BOERHAAVIA DIFFUSA EXTRACT; CALCIUM; CELL PROTEIN; LACTATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; THIOREDOXIN REDUCTASE; VALINOMYCIN;

ANIMAL CELL; ARTICLE; BOERHAVIA DIFFUSA; CALCIUM CELL LEVEL; CALCIUM HOMEOSTASIS; CELL PROTECTION; CELL STRAIN; CELL STRAIN H9C2; CELL VOLUME; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG ISOLATION; EMBRYO; HEART HYPERTROPHY; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART MUSCLE OXYGEN CONSUMPTION; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL PERMEABILITY; MITOCHONDRION SWELLING; MYOBLAST; NONHUMAN; PROTEIN CONTENT; RAT; RESPIRATORY CHAIN;

ANGIOTENSIN II; ANIMALS; CALCIUM; CARDIOMEGALY; CELL LINE; CELL SIZE; HEART; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA, HEART; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MITOCHONDRIAL SWELLING; MYOCARDIUM; NYCTAGINACEAE; OXIDATIVE STRESS; PLANT EXTRACTS; RATS; REACTIVE OXYGEN SPECIES; SUPEROXIDES;

EID: 84899754146     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096220     Document Type: Article

References (64)

1. Rafieian-kopaei M, Shahinfard N, Rouhi-Boroujeni H, Gharipour M, Darvishzadeh-Boroujeni P (2014) Effects of Ferulago angulata extract on serum lipids and lipid peroxidation. Evid Based Compl Alt Med 2014: 1-4. doi.org/10.1155/2014/680856.
2. Bayeva M, Ardehali H (2010). Mitochondrial dysfunction and oxidative damage to Sarcomeric Proteins. Curr Hyp Rep 12: 426-432.
3. Liu CJ, Cheng YC, Lee KW, Hsu HH, Chu CH, et al. (2008) Lipopolysaccharide induces cellular hypertrophy through calcineurin/NFAT-3 signalling pathway in H9c2 myocardiac cells. Mol Cell Biochem 313: 167-178.
4. Takimoto E, Kass DA (2007) Role of oxidative stress in cardiac hypertrophy and remodelling. Hypertension 49: 241-248. (Pubitemid 46142995)
5. Rimbaud S, Garnier A, Ventura-Clapier R (2009) Mitochondrial biogenesis in cardiac pathophysiology. Pharmacol Rep 61: 131-138.
6. Osterholt M, Nguyen TD, Schwarzer M, Doenst T (2012) Alterations in mitochondrial function in cardiac hypertrophy and heart failure. Heart Fail Rev 18: 645-656.
7. Dai DF, Johnson SC, Villarin JJ, Chin MT, Cintrón MN, et al. (2011) Mitochondrial oxidative stress mediates angiotensin II-induced cardiac hypertrophy and gáq overexpression-induced heart failure. Circulation Res 108: 837-846.
8. Doughan AK, Harrison DG, Dikalov SI (2008) Molecular Mechanisms of Angiotensin II-Mediated Mitochondrial Dysfunction: Linking Mitochondrial Oxidative Damage and Vascular Endothelial Dysfunction. Circulation Res 102: 488-496. (Pubitemid 351651106)
9. Shukla SK, Gupta S, Ojha SK, Sharma SB (2010) Cardiovascular friendly natural products: a promising approach in the management of CVD. Nat Prod Res 24: 873-898.
10. Pandey KB, Rizvi SY (2009) Plant polyphenols as dietary antioxidants in human health and disease. Oxid Med Cell Longev 2: 270-278.
11. Riya MP, Antu KA, Vinu T, Chandrakanth KC, Anilkumar KS, et al. (2013) An in vitro study reveals nutraceutical properties of Ananas comosus (L.) Merr. var. Mauritius fruit residue beneficial to diabetes. J Sci Food Agric 94: 943-950.
12. Wallace TC (2011) Anthocyanins in cardiovascular disease. Adv Nutr 2: 1-7.
13. Vineetha VP, Girija S, Soumya RS, Raghu KG (2014) Polyphenol-rich apple (Malus domestica L.) peel extract attenuates arsenic trioxide induced cardiotoxicity in H9c2 cells via its antioxidant activity. Food Funct 5: 502-511
14. Munasinghe TCJ, Seneviratne CK, Thabrew IM, Abeysekera AM (2001) Antiradical and antilipoperoxidative effects of some plant extracts used by Sri Lankan traditional medical practitioners for cardioprotection. Phytother Res 15: 519-523. (Pubitemid 32906437)
15. Agrawal M, Nandini D, Sharma V, Chauhan NS (2010) Herbal remedies for the treatment of hypertension. Int J Pharm Sci and Res 1: 1-21.
16. Prathapan A. Singh MK, Anusree SS, Sobankumar DR, Sundaresan A, et al. (2011) Antiperoxidative, free radical scavenging and metal chelating activities of Boerhaavia diffusa L. J Food Biochem 35: 1548-1554
17. Pari L, Satheesh AM (2004) Antidiabetic effect of Boerhaavia diffusa: effect on serum and tissue lipids in experimental diabetes. J Med Food 7: 472-476. (Pubitemid 40095849)
18. Manu KA, Kuttan G (2009) Immunomodulatory activities of Punarnavine, an alkaloid from Boerhaavia diffusa. Immunopharmacol Immunotoxicol 31(3): 377-387.
19. Kaur M, Goel RK (2011) Anti-convulsant activity of Boerhaavia diffusa: Plausible role of calcium channel antagonism. Evid Based Compl Alt Med doi:10.1093/ecam/nep192.
20. Sreeja S, Sreeja S (2009) An in vitro study on antiproliferative and antiestrogenic effects of Boerhaavia diffusa L. extracts. J Ethnopharmacol 126: 221-225.
21. Prathapan A, Vineetha VP, Abhilash PA, Raghu KG (2013) Boerhaavia diffusa L. attenuates angiotensin II-induced hypertrophy in H9c2 cardiac myoblast cells via modulating oxidative stress and down-regulating NF-êâ and transforming growth factor â1. Br J Nutr 110: 1201-1210.
22. Raghu KG, Cherian OL (2009) Characterization of cytotoxicity induced by arsenic trioxide (a potent anti-APL drug) in rat cardiac myocytes. J Trace Elem Med Biol 23: 61-68.
23. Mukhopadhyay P, Rajesh M, Yoshihiro K, Hasko G, Pacher P (2007) Simple quantitative detection of mitochondrial superoxide production in live cells. Biochem Biophys Res Comm 358: 203-208. (Pubitemid 46719103)
24. Quin F, Patel R, Yan C, Liu W (2006) NADPH oxidase is involved in angiotensin II-induced apoptosis in H9C2 cardiac muscle cells: Effects of apocynin. Free Radical Biol Med 40: 236-246. (Pubitemid 43069349)
25. + exchanger isoform 1 inhibition is mediated by reduced mitogen-activated protein kinase activation secondary to improved mitochondrial integrity and decreased generation of mitochondrial-derived reactive oxygen species. J Pharmacol Exp Therap 317: 1036-1043.
26. Kristal BS, Park BK, Yu BP (1996) 4-hydroxy hexanal is a potent inducer of the mitochondrial permeability transition. J Biol Chem 271: 6033-6038. (Pubitemid 26095405)
27. Paul MK, Kumar R, Mukhopadhyay AK (2008) Dithiothreitol abrogates the effect of arsenic trioxide on normal rat liver mitochondria and human hepatocellular carcinoma cells. Toxicol Appl Pharmacol 226: 140-152. (Pubitemid 350297346)
28. Sudheesh NP, Ajith T, Janardhanan KK (2009) Ganoderma lucidum (Fr.) P. Karst enhances activities of heart mitochondrial enzymes and respiratory chain complexes in the aged rat. Biogerontol 10: 627-636.
29. Vineetha VP, Prathapan A, Soumya RS, Raghu KG (2013) Arsenic trioxide toxicity in H9c2 myoblasts-damage to cell organelles and possible amelioration with Boerhavia diffusa . Cardiovasc Toxicol 13: 123-137.
30. Rooban BN, Sasikala V, Sahasranamam V, Abraham A (2010) Vitex negundo modulates selenite-induced opacification and cataractogensis in rat pups. Biol Trace Elem Res 138: 282-92.
31. Petronilli V, Miotto G, Canton M, Brini M, Colonna R, et al. (1999) Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys J 76: 725-734. (Pubitemid 29264555)
32. Lin CJ, Lee CC, Shih YL, Lin CH, Wang SH, et al. (2012) Inhibition of mitochondria and endoplasmic reticulum stress-mediated autophagy augments temozolomide-induced apoptosis in glioma cells. Plos One 7(6): e38706.
33. Rosca MG, Hoppel CL (2010) Mitochondria in heart failure. Cardiovasc Res 88: 40-50.
34. Javadov S, Karmazyn M, Escobales N (2009) Mitochondrial permeability transition pore opening as a promising therapeutic target in cardiac diseases. J Pharmacol Exp Ther 330: 670-678.
35. Rocha M, Apostolova N, Hernace JR, Hernandez-Mijares A, Victor VM (2014) Perspectives and potential applications of mitochondria-targeted antioxidants in cardiometabolic diseases and Type 2 diabetes. Med Res Rev 34:160-89.
36. Ritchie RH, Delbridge LMD (2006) Cardiac hypertrophy, substrate utilization and metabolic remodelling: cause or effect? Clin Exp Pharmacol Physiol 33: 159-166.
37. Abel1 ED, Doenst T (2011) Mitochondrial adaptations to physiological vs pathological cardiac hypertrophy. Cardiovasc Res 90: 234-242.
38. Lin CS, Sun YL, Liu CY (2003) Structural and biochemical evidence of mitochondrial depletion in pigs with hypertrophic cardiomyopathy. Res Vet Sci 74: 219-226. (Pubitemid 36622115)
39. Ji K, Minakawa M, Fukui K, Suzuki Y, Fukuda I (2008) Increased superoxide radical with a decrease in vascular endothelial growth factor and inducible nitric oxide synthase level leads to the progression of left ventricular hypertrophy in a pressure-overload rat heart model. Ann thorac Cardiovasc Surg 14: 210-217.
40. Murdoch CE, Zhang M, Cave AC, Shah AM (2006) NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure. Cardiovas Res 71: 208-215.
41. Hajjar RJ, Leopold JA (2006) Xanthine oxidase inhibition and heart failure-novel therapeutic strategy for ventricular dysfunction. Circulation Res 98: 169-171.
42. Seddon M, Looi YH, Shah AM (2007) Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 93: 903-907. (Pubitemid 47122034)
43. Correa F, Buelna-Chontal M, Hernandez-Resendiz S, Garcia-Nino WR, Roldan FJ, et al. (2013) Curcumin maintains cardiac and mitochondrial function in chronic kidney disease. Free Radical Biol Med 61: 119-129.
44. Takemoto M, Node K, Nakagami H, Liao Y, Grimm M, et al. (2001) Statins as antioxidant therapy for preventing cardiac myocyte hypertrophy. J Clin Invest 108: 1429-1437. (Pubitemid 33091980)
45. Ahsan MK, Lekli I, Ray D, Yodoi J, Das DK (2009) Redox regulation of cell survival by the thioredoxin superfamily: an implication of redox gene therapy in the heart. Antioxidants Redox Signal 11: 2741-2758.
46. Javadov S, Karmazyn M (2007) Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection. Cell Physiol Biochem 2007; 20:1-22. (Pubitemid 46956808)
47. Matsumoto S, Friberg H, Ferrand-Drake M, Wieloch T (1999) Blockade of the mitochondrial permeability transition pore diminishes infarct size in the rat after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab 19 (7): 736-741. (Pubitemid 30159798)
48. Wang G, Hamid T, Keith RJ, Zhou G, Partridge CR, et al. (2010) Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart. Circulation 121:1912-1925.
49. Sudheesh NP, Ajith TA, Janardhanan KK (2013) Ganoderma lucidum ameliorate mitochondrial damage in isoproterenol-induced myocardial infarction in rats by enhancing the activities of TCA cycle enzymes and respiratory chain complexes. Int J Cardiol 165, 117-125.
50. Chan SHH, Wu KLH, Chang AYW, Tai M, Chan JYH (2009) Oxidative impairment of mitochondrial electron transport chain complexes in rostral ventrolateral medulla contributes to neurogenic hypertension. Circulation 53:217-227.
51. Will Y, Hynes J, Ogurtov VI, Papovsky DB (2006) Analysis of mitochondrial function using phosphorescent oxygen-sensitive probes. Nat Protocol 1: 1-10.
52. Cassis L, Helton M, English V, Burke G (2002) Angiotensin II regulates oxygen consumption. Am J Physiol Regulatory Integrative Comp Physiol 282: R445-R453. (Pubitemid 34664595)
53. Brookes SP, Yoon Y, Robotham JL, Anders MW, Sheu SS (2004) Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol 287: C817-C833. (Pubitemid 39238305)
54. Kim HS, Hwang KC, Park WK (2010) Cardioprotection via modulation of calcium homeostasis by thiopental in hypoxia-reoxygenated neonatal rat cardiomyocytes. Yonsei Med J 51:187-196.
55. Ott M, Robertson JD, Gogvadze V, Zhivotovsky B, Orrenius S (2002) Cytochrome c release from mitochondria proceeds by a two-step process. Proc Natl Acad Sci USA 99: 1259-1263. (Pubitemid 34136480)
56. Bayeva M, Gheorghiade M, Ardehali H (2013) Mitochondria as a therapeutic target in heart failure. J Am Coll Cardiol 61: 599-610.
57. Ferreres F, Sousa C, Justin M, Valentão P, Andrade PB, et al. (2005) Characterization of phenolic profile of Boerhaavia diffusa L. by HPLC-PAD-MS/MS as tool for quality control. Phytochem Anal 16, 451-458. (Pubitemid 41701172)
58. Yan L, Zhang JD, Wang B, Lv YJ, Jiang H, et al. (2013) Quercetin inhibits left ventricular hypertrophy in spontaneously hypertensive rats and inhibits angiotensin II-induced h9c2 cells hypertrophy by enhancing PPAR-ã expression and suppressing ap-1 activity. Plos One 8(9): e72548.
59. Larson AJ, Symons JD, Jalili T (2012) Therapeutic potential of quercetin to decrease blood pressure: Review of efficacy and mechanisms. Adv Nutr 3: 39-46.
60. Liobikas J, Majiene D, Trumbeckaite S, Kursvietiene L, Masteikova R, et al. (2011) Uncoupling and antioxidant effects of ursolic acid in isolated rat heart mitochondria. J Nat Prod 22: 74(7): 1640-4.
61. Pandey R, Maurya R, Singh G, Sathiamoorthy B, Naik S (2005) Immunosuppressive properties of flavonoids isolated from Boerhaavia diffusa Linn. Int Immunopharmacol 5: 541-553. (Pubitemid 40430761)
62. Calderon-Montano JM, Burgos-Moron E, Perez-Guerrero C, López-Lázaro M (2011) A review on the dietary flavonoid kaempferol. Mini Rev Med Chem 11, 298-344.
63. Aviello G, Canadanovic-Brunet JM, Milic N, Capasso R, Fattorusso E, et al. (2011) Potent antioxidant and genoprotective effects of Boeravinone G, a rotenoid isolated from Boerhaavia diffusa. Plos One 6: e19628.
64. Lami N, Kadota S, Kikuchi T, Momose Y (1991) Constituents of the roots of Boerhaavia diffusa L. III. Identification of a calcium channel antagonistic compound from the methanol extract. Chem Pharm Bull 39: 1551-1555.